Abstract
The goal of my laboratory is to understand the molecular genetics basis of the inflammatory skin disease psoriasis and associated psoriatic arthritis. In performing these studies my colleagues and I have begun to identify common pathways leading to autoimmunity as well, because some of the defective pathways leading to autoimmunity are the same in different autoimmune diseases. Some of these pathways are involved in determining the activation status of inflammatory cells in the resting state. Other pathways are likely to determine target organ specificity and will be unique to a particular disease. Our approaches rely on genetic studies with cases and families to identify the causative variants, and then functional studies to identify the role of these variants in the predisposition to psoriasis and autoimmunity. The advantage of genetics approaches to understanding diseases such as those of the immune system is that one can identify novel genes and pathways that were not previously suspected as being involved in either the immune system or tolerance.
Similar content being viewed by others
References
Jacobson DL, Gange SJ, Rose NR, Graham NM: Epidemiology and estimated population burden of selected autoimmune diseases in the United States. Clin Immunol Immunopathol 1997;84:223–243.
Adebajo AO: Low frequency of autoimmune disease in tropical Africa [comment]. Lancet 1997;349:361, 362.
Collado-Mesa F, Barcelo A, Arheart KL, Messiah SE: Analisis ecologico de la incidencia y prevalencia en America Latina de diabetes tipo 1 con inicio en la ninez [An ecological analysis of childhood-onset type 1 diabetes incidence and prevalence in Latin America]. Rev Panam Salud Publica 2004;15:388–394.
Lea JP: Lupus nephritis in African Americans. Am J Med Sci 2002;323:85–89.
Bowcock AM, Cookson WO: The genetics of psoriasis, psoriatic arthritis and atopic dermatitis. Hum Mol Genet 2004;13:R43-R55.
Eisenberg R: Mechanisms of autoimmunity. Immunol Res 2003;27:203–218.
Becker KG, Simon RM, Bailey-Wilson JE, et al.: Clustering of non-major histocompatibility complex susceptibility candidate loci in human autoimmune diseases. Proc Natl Acad Sci USA 1998;95:9979–9984.
Helms C, Cao L, Krueger JG, et al: A putative RUNX1 binding site variant between SLC9A 3R1 and NAT9 is associated with susceptibility to psoriasis [see comment]. Nat Genet 2003;35:349–356.
Perez-Lorenzo R, Zambrano-Zaragoza JF, Saul A, Jimenez-Zamudio L, Reyes-Maldonado E, Garcia-Latorre E: Autoantibodies to autologous skin in guttate and plaque forms of psoriasis and cross-reaction of skin antigens with streptococcal antigens. Int J Dermatol 1998;37:524–531.
Ockenfels HM: [Trigger factors for psoriasis]. Hautarzt 2003;54:215–223.
Zandman-Goddard G, Shoenfeld Y: HIV and autoimmunity. Autoimmun Rev 2002;1:329–337.
Morton NE, Collins A: Toward positional cloning with SNPs. Curr Opin Mol Ther 2002;4:259–264.
Zhang K, Qin ZS, Liu JS, Chen T, Waterman MS, Sun F: Haplotype block partitioning and tag SNP selection using genotype data and their applications to association studies. Genome Res 2004;14:908–916.
Buckley RH: Transplantation immunology: organ and bone marrow. J Allergy Clin Immunol 2003;111:S733-S744.
Wong FS, Wen L: The study of HLA class II and autoimmune diabetes. Curr Mol Med 2003;3:1–15.
Tiilikainen A, Lassus A, Karyonen J, Vartiainen P, Julin M: Psoriasis and HLA-Cw6. Br J Dermatol 1980;102:179–184.
Capon F, Munro M, Barker J, Trembath R: Searching for the major histocompatibility complex psoriasis susceptibility gene. J Invest Dermatol 2002;118:745–751.
Tomfohrde J, Silverman A, Barnes R, et al: Gene for familial psoriasis susceptibility mapped to the distal end of human chromosome 17q. Science 1994;264:1141–1145.
Alkhateeb A, Stetler GL, Old W, et al: Mapping of an autoimmunity susceptibility locus (AIS1) to chromosome 1p31.3-p32.2. Hum Mol Genet 2002;11:661–667.
Lacaud G, Gore L, Kennedy M, et al: Runx 1 is essential for hematopoietic commitment at the hemangioblast stage of development in vitro. Blood 2002;100:458–466.
Osato M, Yanagida M, Shigesada K, Ito Y: Point mutations of the RUNx 1/AML 1 gene in sporadic and familial myeloid leukemias. Int J Hematol 2001;74:245–251.
Prokunina L, Castillejo-Lopez C, Oberg F, et al: A regulatory polymorphism in PDCD 1 is associated with susceptibility to systemic lupus erythematosus in humans. Nat Genet 2002;32:666–669.
Tokuhiro S, Yamada R, Chang X, et al: An intronic SNP in a RUNX1 binding site of SLC22A4, encoding an organic cation transporter, is associated with rheumatoid arthritis [see comment]. Nat Genet 2003;35:341–348.
Peltekova VD, Wintle RF, Rubin, LA, et al: Functional variants of OCTN cation transporter genes are associated with Crohn disease. Nat Genet 2004;36:471–475.
Reczek D, Berryman M, Bretscher A: Identification of EBP50: a PDZ-containing phosphoprotein that associates with members of the ezrin-radixin-moesin family. J Cell Biol 1997;139:169–179.
Begovich AB, Carlton VE, Honigberg LA, et al: A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis. Am J Hum Genet 2004;75:330–337.
Bottini N, Musumeci L, Alonso A, et al: A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes. Nat Genet 2004;36:337, 338.
Kyogoku C, Langefeld CD, Ortmann WA, et al: Genetic association of the R620W polymorphism of protein tyrosine phosphatase PTPN22 with human SLE. Am J Hum Genet 2004;75:504–507.
Ueda H, Howson JM, Esposito L, et al: Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature 2003;423:506–511.
Guo D, Li M, Zhang Y, et al: A functional variant of SUMO4, a new IkappaBalpha modifier, is associated with type 1 diabetes. Nat Genet 2004;36:837–841.
Hugot JP, Chamaillard M, Zouali H, et al: Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn’s disease. Nature 2001;411:599–603.
Rahman P, Bartlett S, Siannis F, et al: CARD15: a pleiotropic autoimmune gene that confers susceptibility to psoriatic arthritis. Am J Hum Genet 2003;73:677–681.
Hewett D, Samuelsson L, Polding J, et al: Identification of a psoriasis susceptibility candidate gene by linkage disequilibrium mapping with a localized single nucleotide polymorphism map. Genomics 2002;79: 305–314.
Hebert SC, Mount DB, Gamba G: Molecular physiology of cation-coupled Cl-cotransport: the SLC12 family. Pflügers Arch 2004;447:580–593.
Shenolikar S, Voltz JW, Minkoff CM, Wade JB, Weinman EJ: Targeted disruption of the mouse NHERF-1 gene promotes internalization of proximal tubule sodium-phosphate contransporter type IIa and renal phosphate wasting. Proc Natl Acad Sci USA 2002;99: 11,470–11,475.
Gisler SM, Probanic S, Bacic D, et al: PDZK1: I. A major scaffolder in brush borders of proximal tubular cells. Kidney Int 2003;64:1733–1745.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bowcock, A.M. Understanding the pathogenesis of psoriasis, psoriatic arthritis, and autoimmunity via a fusion of molecular genetics and immunology. Immunol Res 32, 45–56 (2005). https://doi.org/10.1385/IR:32:1-3:045
Issue Date:
DOI: https://doi.org/10.1385/IR:32:1-3:045